The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQRT.L Regulatory News (QRT)

  • There is currently no data for QRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Grant of Share Options

15 May 2017 07:38

RNS Number : 0999F
Quarto Group Inc
15 May 2017
 

The Quarto Group, Inc

("the Company")

PDMR Grant of Share Options

 

The Quarto Group (LSE: QRT), the leading global illustrated book publisher, announces that on 5 May 2017 it has granted 137,306 options under the Company's existing Performance Share Plan to Persons Discharging Managerial Responsibility ("PDMRs") as listed below. The awards have a vesting date of 28 April 2021.

 

PDMR

Position

Number of Options granted

David Breuer

Chief Creative Officer

16,635

Anne Crompton

Group Director of Legal & Business Affairs

10,932

Ken Fund

Chief Operating Officer

25,496

Marcus Leaver

Chief Executive officer

70,935

Karine Marko

Group Director of Foreign Rights

13,308

Dorothee de Montgolfier

Group Director of Communications

7,605

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

 

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

1. David Breuer

2. Anne Crompton

3. Ken Fund

4. Marcus Leaver

5. Karine Marko

6. Dorothee de Montgolfier

2

Reason for the notification

a)

Position/status

Classified as PDMRs of the Company

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

The Quarto Group Inc

b)

LEI

[N/A]

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Common stock of US$0.10 each in the capital of the Company ("Common Stock")

Identification code

US74772E1001

b)

Nature of the transaction

Grant of options over Common Stock

c)

Price(s) and volume(s)

Exercise Prices per share

Volumes

 

1. Nil Cost Options

2. Nil Cost Options

3. Nil Cost Options

4. Nil Cost Options

5. Nil Cost Options

6. Nil Cost Options

1. 16,635

2. 10,932

3. 25,496

4. 70,935

5. 13,308

6. 7,605

d)

Aggregated information

- Aggregated volume

- Price

Aggregated volume: 137,306

Price: Nil cost options

e)

Date of the transaction

5 May 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

For further information, please contact:

 

The Quarto Group

Marcus Leaver, CEO

Dorothée de Montgolfier, Group Director of Communications

020 7700 9002

 

Bell Pottinger

Elly Williamson

020 3772 2573

About The Quarto Group

The Quarto Group (LSE: QRT) is the leading global illustrated book publishing group. Our mission is to make and sell great books that entertain, educate and enrich the lives of adults and children around the world.

Quarto creates and owns proprietary content, publishing books from a diverse portfolio of imprints that are creatively independent and expert in developing long-lasting content across specific niches of interest.

Quarto sells books across 50 countries and in 39 languages through a variety of traditional and non-traditional channels, while constantly looking for new ways to create and deliver content that people need.

Quarto employs over 400 talented people in the US, UK and Hong Kong. The group was founded in London in 1976. It is domiciled in the US and listed on the London Stock Exchange. 

For more information, visit quarto.com or follow us on Twitter at @TheQuartoGroup.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSFWSMIFWSEDI
Date   Source Headline
8th Sep 20205:02 pmRNSDirector/PDMR Shareholding
28th Jul 20203:45 pmRNSHalf-year Report
24th Jun 20203:16 pmRNSResult of Annual Meeting
28th May 20209:50 amRNSAnnual Financial Report
23rd Apr 20207:00 amRNSFinal Results
25th Mar 20209:57 amRNSTrading Statement
25th Mar 20207:00 amRNSTrading Statement
26th Feb 20201:10 pmRNSHolding(s) in Company
10th Feb 20202:29 pmRNSDirectorate Change
6th Feb 20209:13 amRNSHolding(s) in Company
4th Feb 20207:00 amRNSDirector/PDMR Shareholding
3rd Feb 20207:00 amRNSResult of Open Offer
31st Jan 202010:35 amRNSResult of Special Meeting
28th Jan 20205:42 pmRNSStatement re: Media Speculation
16th Jan 20203:45 pmRNSPublication of Prospectus and Circular
16th Jan 20207:00 amRNSOpen Offer to raise £13.9 million
15th Jan 20206:26 pmRNSIntention to launch an Open Offer
8th Nov 20194:32 pmRNSChange of Adviser
16th Aug 20197:00 amRNSHalf-Year Results
11th Jul 20198:17 amRNSChange of Broker
1st Jul 20191:30 pmRNSAppointment of CFO
14th Jun 20195:29 pmRNSHolding(s) in Company
11th Jun 20193:42 pmRNSHolding(s) in Company
11th Jun 201911:00 amRNSHolding(s) in Company
10th Jun 20195:32 pmRNSDirector/PDMR Shareholding
16th May 20195:12 pmRNSAnnual Meeting Result
25th Apr 20194:59 pmRNSAppointment of Non-Executive Director & CFO
23rd Apr 20194:59 pmRNSAnnual Financial Report
14th Mar 20193:33 pmRNSDirector Declaration
11th Mar 20197:00 amRNSFinal Results for the Year Ended 31 December 2018
27th Feb 20192:56 pmRNSDirector Declaration
6th Dec 20181:27 pmRNSDirector/PDMR Shareholding
14th Nov 20184:01 pmRNSDirector/PDMR Shareholding
12th Nov 20187:00 amRNSDirector Declaration
1st Nov 20187:00 amRNSExtension and amendment of banking facilities
15th Oct 20183:05 pmRNSDirector Declaration
17th Sep 20187:00 amRNSHalf-year Report
15th Aug 201811:30 amRNSSpecial Meeting result
30th Jul 20188:00 amRNSNotice of Special Meeting of Shareholders
26th Jul 201811:06 amRNSBoard change
17th Jul 20183:25 pmRNSBoard appointment disclosure
12th Jul 201812:05 pmRNSBoard changes
5th Jun 201811:09 amRNSCFO Resignation & Board Change
24th May 20183:10 pmRNSCEO resignation
22nd May 201811:55 amRNSListing Rule 9.6.13R Disclosure
17th May 20185:49 pmRNSUpdate on roles of new Directors
17th May 20185:45 pmRNSChange of Control
17th May 201812:24 pmRNSAnnual Meeting statement and result
2nd May 20185:45 pmRNSHolding(s) in Company
23rd Apr 20187:00 amRNSAnnual Report and Notice of Annual Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.